Preview_part_of_someone_s_survival_guide

This is exactly what WhatNext is all about. Sharing your stories, your failures, and your victories so someone else can have a better idea of what to expect, what to ask, and what to do.

Thank you all for your support!

WhatNextEmails' Avatar
WhatNextEmails shared a photo
Preview_newsletter-icon-17

February Newsletter is Out

You should receive the newsletter in your email inbox that you used to register on the site, but some of you may not get it due to the email problem our system had over the weekend. You can click this link https://conta.cc/2DVy6PA to get it.

WhatNextEmails' Avatar
WhatNextEmails shared a photo
Preview_cancer_cell

Someone emailed us a link to these amazing pictures of cancer cells. While they are killers, these pictures are also pretty amazing.

See striking and bizarre images of cancer cells
Scientists from Australia find stunning art in the course of their medical research.

The Art of Science, an exhibition in Melbourne, Australia, has taken on the interesting challenge of blending art and a healthy dose of science education.

The free exhibition, held at the Federation Square in the city, features images and videos taken from medical research, and the pictures of cancer cells or protein structures are visually stunning.

With five days left to go before the exhibition closes on Aug. 19, it's likely not all of us can hop on a plane to head Down Under, so check out the gallery below for a peek.
https://www.cnet.com/news/see-striking-and-bizarre-new-images-of-cancer-cells/?ftag=COS-05-10aaa0h

WhatNextEmails' Avatar
WhatNextEmails shared a photo
Preview_0

Someone recently asked for some information about videos that would help with exercises to strengthen bones. Here is one that looked pretty good.

WhatNextEmails' Avatar
WhatNextEmails shared a video
Preview_linnea_olson_and_kumo

Targeting Cancer-The dawn of precision medicine
INNEA OLSON tells her story—of repeatedly facing death, then being saved by the latest precision therapy—articulately and thoughtfully, agreeing to discuss subjects that might otherwise be too personal, she says, because it could benefit other patients. She lives in an artist cooperative in Lowell, Massachusetts, in an industrial space, together with her possessions and artwork, which fill most of an expansive high-ceilinged room. Olson is tall, with close-cropped, wavy blonde hair, and dresses casually in faded blue jeans. Although she has an open, informal style, this is paired with a natural dignity and a deliberate manner of speaking.

“I had a young doctor who was very good,” she begins. “I presented with shortness of breath and a cough, and also some strange weakness in my upper body. And he ordered a chest x-ray.” Years later, she saw in her chart that he had written, “On the off chance that this young, non-smoking woman has a neoplasm”—the beginnings of a tumor in her left lung. But he didn’t mention that to her, and “he ended up getting killed on 9/11—he was on one of the planes that hit the towers.”

The national tragedy thus rippled into Olson’s life. Never suspecting that her symptoms could be caused by cancer, she spent the next several years seeking a diagnosis. A string of local doctors told her it was adult-onset asthma, hypochondria, then pneumonia. When antibiotics didn’t clear the pneumonia, a CT scan showed a five-centimeter mass in her left lung: an infection? Or cancer? It was the first time she had heard that word. The technicians told her that at 45, she was too young for that. But a biopsy confirmed the diagnosis. “In 2005, when you told someone they had lung cancer,” a doctor later told her, “you were basically saying you were sorry.” Her youngest son was seven at the time. Olson wanted to live.

Now, 13 years later, she is alive and healthy, a testament to the potential of precision medicine to extend lives. But like precision medicine itself, her story encapsulates the best and worst of what medicine can offer, as converging forces in genetics, data science, patient autonomy, health policy, and insurance reimbursement shape its future. There are miraculous therapies and potentially deadly side effects; tantalizing quests for cures that come at increasingly high costs; extraordinary advances in basic science, despite continuing challenges in linking genes implicated in disease to biological functions; inequities in patient care and clinical outcomes; and a growing involvement of patients in their own care, as they share experiences, emotions, and information with a global online community, and advocate for their own well-being.

Precision medicine is not really new. Doctors have always wanted to deliver increasingly personalized care. The current term describes a goal of delivering the right treatment to the right patient at the right time, based on the patient’s medical history, genome sequence, and even on information, gathered from wearable devices, about lifestyle, behaviors, or environmental exposures: healthcare delivered in an empiric way. When deployed at scale, this would, for example, allow doctors to compare their patient’s symptoms to the histories of similar patients who have been successfully treated in the past. Treatments can thus be tailored to particular subpopulations of patients. To get a sense of the promise of precision medicine—tantalizingly miraculous at times, yet still far from effective implementation—the best example may be cancer, which kills more than 595,000 Americans each year.

See complete Article Here - From Harvard Magazine
https://harvardmagazine.com/2018/05/precision-medicine-cancer

WhatNextEmails' Avatar
WhatNextEmails shared a photo